Cancer Care Centers of South Texas-HOAST

San Antonio, Texas 78229

0 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, Cancer, Advanced Solid Tumors, DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, Hematologic Malignancy, Metastatic Breast Cancer, Multiple Myeloma, Myelodysplastic Syndromes, Non-small Cell Lung Cancer, Urothelial Cancer, de Novo DLBCL

Studies at this site

• Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments — Completed
• Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes — Completed
• A Study of BBI503 in Adult Patients With Advanced Solid Tumors — Completed
• A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed
• A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma — Stopped early
• Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes — Completed
• Ixabepilone + Carboplatin Metastatic Breast Cancer — Completed
• Gemzar, Cisp, Sunitinib Urothelial Ca — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed